| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/14/2004 | EP1040097B1 Potassium channel openers |
| 04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 04/14/2004 | EP0935465B1 Novel substituted imidazole compounds |
| 04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
| 04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
| 04/14/2004 | CN1489585A Process for producing substituted 2-(2-pyridylmethye)sulfinye-1H-benzinmidazoles |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1489477A Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use |
| 04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
| 04/14/2004 | CN1489467A Pharmacentical formulation comprising pyrazolo[4,3-d] pyrimdine and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/14/2004 | CN1488761A A double-stranded DNA molecule and its use in preparing medicine for inhibiting hepatitis B virus replication |
| 04/14/2004 | CN1488743A Supplemental strengthening wine and preparing process thereof |
| 04/14/2004 | CN1488637A Method for preparing total aglycone extract of radix picrorrhizae |
| 04/14/2004 | CN1488397A Gallbladder-cooling speelen-tonifying capsule |
| 04/14/2004 | CN1488393A Chinese medicine composition for treating fang deficiency of epigastric pain and preparing method thereof |
| 04/14/2004 | CN1488390A Chinese medicine formulation for treating mouth ulcer and tongue furunculosis and preparing method thereof |
| 04/14/2004 | CN1488387A Spleen tonifying tea |
| 04/14/2004 | CN1488381A Artichoke leaf cream extracting technique |
| 04/14/2004 | CN1488376A Medicinal cap sule for treating enteric disease and nusosinusitis and preparing method thereof |
| 04/14/2004 | CN1488372A Chinese medicine formual for treating heptitis |
| 04/14/2004 | CN1488345A Ranitidine hydrochloride capsule producing process |
| 04/14/2004 | CN1488343A Tiopronin freeze-dried powder injection |
| 04/14/2004 | CN1488341A Ginseng-monkshood slow-release microporous for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488340A Ginseng-monkshood slow-release coating film controlled tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488339A Ginseng-monkshood slow-release coating skeleton piller for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488338A Ginseng-monkshood slow-release coating preparation film controlled piller for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488337A Ginseng-monkshood slow-release coating microporous film coated tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488336A Gineng-monkshood skeleton slow-releae insoluble skeleton tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488335A Ginseng-monkshood skeleton slow-release endo gastric detention tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488334A Ginseng-monkshood skeleton slow-release preparation wax skeleton tablet for treating qi athenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1488333A Ginseng-monkshood skeleton slow-release hydrophilic gel skeleton tablet for treating qi asthenia and yang depletion and preparing method thereof |
| 04/14/2004 | CN1145637C Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
| 04/14/2004 | CN1145624C New Process |
| 04/14/2004 | CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same |
| 04/14/2004 | CN1145606C 2-aminotetrahydronaphthalene, process for their preparation, and pharmaceutical composition for prevention and therapeutic treatment of in flammatory and lor autoimmune pathologies |
| 04/14/2004 | CN1145495C Orally applied medicine for treating diseases caused by Yang deficciency and its producing method |
| 04/14/2004 | CN1145489C Inositol polyphosphate derivatives and mthod of using same |
| 04/14/2004 | CN1145487C Use of allopurinol for medical purpose |
| 04/13/2004 | US6720354 Prevention of neutrophil recruitment |
| 04/13/2004 | US6720353 Purified plant proanthocyanidin extract, capable of inhibiting agglutination of P-type Escherichia coli and not capable of inhibiting agglutination of type 1 Escherichia coli; proanthocyanidin having 4-12 epicatechin flavanoid units |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720336 4,4-biarylpiperidine derivatives |
| 04/13/2004 | US6720329 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) |
| 04/13/2004 | US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) |
| 04/13/2004 | US6720327 Lactone integrin antagonists |
| 04/13/2004 | US6720325 CCR5 antagonists useful for treating aids |
| 04/13/2004 | US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 04/13/2004 | US6720320 Phenoxypropylamine compounds |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
| 04/13/2004 | US6720014 Culturing escherichia coli; genetic engineering and expression |
| 04/13/2004 | US6720010 Composition having antihepatitic activity |
| 04/13/2004 | US6719995 Flexible polybutene strips for preventing gingivitis/whitening of teeth |
| 04/13/2004 | US6719968 For therapy of tendinitis, or other tendon or ligament defect |
| 04/13/2004 | US6719963 Liquid oral compositions comprising a calcium compound and an acidulant |
| 04/08/2004 | WO2004029058A1 Medicinal composition for inhibiting increase in blood gastrin concentration |
| 04/08/2004 | WO2004029057A1 Medicinal composition for treatment for or prevention of visceral pain |
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004029041A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | WO2004028525A1 Choline ascorbate formulations |
| 04/08/2004 | WO2004028524A1 Combination drug |
| 04/08/2004 | WO2004028460A2 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 04/08/2004 | WO2004014150A9 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 04/08/2004 | WO2004011444A3 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/08/2004 | WO2004007512A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/08/2004 | WO2004004599A3 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003104473A8 Galactosyl isomalt, method for production and use thereof |
| 04/08/2004 | WO2003100023A3 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration |
| 04/08/2004 | WO2003100008A3 Neutralizing human anti-igfr antibody |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/08/2004 | WO2003080024A3 Nanoparticulate compositions of map kinase inhibitors |
| 04/08/2004 | WO2003068732A3 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 04/08/2004 | US20040068005 Pharmaceutical combinations |
| 04/08/2004 | US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 04/08/2004 | US20040067993 Famotidine injections |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067966 Adenosine receptor antagonists and methods of making and using the same |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067943 Tryptase inhibitors |
| 04/08/2004 | US20040067941 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 04/08/2004 | US20040067932 Synergistic mixture; anticancer agents; therapy for skin cancer |
| 04/08/2004 | US20040067930 Central nervous system disorders; neurotransmitters; side effect reduction |
| 04/08/2004 | US20040067928 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 04/08/2004 | US20040067901 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/08/2004 | US20040067872 Novel mono- and di-fluorinated benzothiepine compouds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |